Respected Madam/Sir, Please find attached letter. Thanks & Regards

Date: Sept 24th ,2026 The Manager, Lis(cid:415)ng department, BSE Limited, P.J. Towers, Dalal Street, Mumbai – 400 001 Scrip Code:-539428 Security ID:-TEJNAKSH Subject: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding publication of scientific validation study of Pflow™ in the Indian Journal of Urology Dear Sir/Madam, Pursuant to Regula(cid:415)on 30 of the SEBI (Lis(cid:415)ng Obliga(cid:415)ons and Disclosure Requirements) Regula(cid:415)ons, 2015, we wish to inform the Stock Exchange that a research paper (cid:415)tled"Prospec(cid:415)ve Mul(cid:415)centric Valida(cid:415)on of a Novel Uroflowmetry Device (Pflow™) Against Conven(cid:415)onal Gravimetric Uroflowmetry" has been published in the Indian Journal of Urology, the official peer-reviewed journal of the Urological Society of India. The study evaluates Pflow™, an innova(cid:415)ve portable uroflowmetry device developed for urine flow assessment. The mul(cid:415)centric prospec(cid:415)ve study involved 372 pa(cid:415)ents across two ter(cid:415)ary urology centers and compared the performance of Pflow™ with conven(cid:415)onal gravimetric uroflowmetry. The publica(cid:415)on reports that the device demonstrated agreement with conven(cid:415)onal uroflowmetry parameters and supports its u(cid:415)lity as a convenient and pa(cid:415)ent-friendly solu(cid:415)on for uroflowmetric evalua(cid:415)on. The publica(cid:415)on features, among others, Dr. Ashish Rawandale-Pa(cid:415)l, Managing Director of Tejnaksh Healthcare Limited, and Dr. Pree(cid:415) Rawandale, Director of Tejnaksh Healthcare Limited, as contribu(cid:415)ng authors. It may further be noted that Pflow™ had earlier gained na(cid:415)onwide recogni(cid:415)on through its appearance on Shark Tank India Season 2 Episode 13, where the innova(cid:415)on was showcased to a na(cid:415)onal audience for its poten(cid:415)al to transform uroflowmetry tes(cid:415)ng by enabling a more convenient and pa(cid:415)ent-centric approach. The recent publica(cid:415)on in the Indian Journal of Urology provides independent scien(cid:415)fic valida(cid:415)on of the technology and marks a significant milestone in the journey of transla(cid:415)ng indigenous medical innova(cid:415)on into evidence-based clinical prac(cid:415)ce. The Company believes that this publica(cid:415)on represents an important scien(cid:415)fic valida(cid:415)on of the Pflow™ technology and reinforces its commitment towards healthcare innova(cid:415)on, research, and pa(cid:415)ent-centric medical solu(cid:415)ons. A copy/link of the publica(cid:415)on is enclosed for reference. h(cid:425)ps://share.google/Oklv6YAyHmDpkn8qY Kindly take the above informa(cid:415)on on record. Thanking You, Yours faithfully, For, Tejnaksh Healthcare Limited Dr. Ashish V. Rawandale Managing Director DIN:-02005733